Stockscreener 앱 받기
83.49
1.14%
-0.96
시간 외 거래:
83.49
전일 마감가:
$84.45
열려 있는:
$83.84
하루 거래량:
949.29K
Relative Volume:
0.98
시가총액:
$3.91B
수익:
$1.35B
순이익/손실:
$163.34M
주가수익비율:
25.48
EPS:
3.2763
순현금흐름:
$189.17M
1주 성능:
-0.54%
1개월 성능:
+14.18%
6개월 성능:
+17.00%
1년 성능:
+1.45%
1일 변동 폭
$82.07
$84.50
1주일 범위
$82.07
$87.32
52주 변동 폭
$47.31
$87.32
Haemonetics Corp Stock (HAE) Company Profile
명칭
Haemonetics Corp
전화
(781) 848-7100
주소
125 SUMMER STREET, BOSTON, MA
HAE을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HAE
Haemonetics Corp
|
83.49 | 3.95B | 1.35B | 163.34M | 189.17M | 3.2763 |
|
ABT
Abbott Laboratories
|
125.46 | 214.37B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
92.58 | 136.01B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
354.09 | 134.98B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
99.87 | 127.88B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.08 | 48.88B | 5.88B | 1.34B | 799.60M | 2.3489 |
Haemonetics Corp Stock (HAE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-11 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2025-08-08 | 재확인 | Barrington Research | Outperform |
| 2025-08-08 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2025-07-09 | 업그레이드 | Citigroup | Neutral → Buy |
| 2025-06-26 | 개시 | Robert W. Baird | Outperform |
| 2025-02-07 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2024-12-06 | 개시 | JP Morgan | Overweight |
| 2024-11-08 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2024-09-13 | 개시 | CL King | Buy |
| 2024-09-11 | 개시 | BofA Securities | Neutral |
| 2024-09-10 | 개시 | BTIG Research | Buy |
| 2024-06-12 | 업그레이드 | Needham | Hold → Buy |
| 2022-10-13 | 개시 | Mizuho | Buy |
| 2022-01-27 | 다운그레이드 | Needham | Buy → Hold |
| 2021-12-15 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2021-08-17 | 재개 | Raymond James | Outperform |
| 2021-06-17 | 개시 | Citigroup | Buy |
| 2021-05-14 | 업그레이드 | CJS Securities | Market Perform → Market Outperform |
| 2021-04-20 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-04-19 | 다운그레이드 | CJS Securities | Market Outperform → Market Perform |
| 2021-02-03 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2021-01-21 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2020-11-05 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2020-05-06 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2020-03-31 | 업그레이드 | CJS Securities | Market Perform → Market Outperform |
| 2020-01-10 | 개시 | Needham | Buy |
| 2019-08-07 | 재확인 | Barrington Research | Outperform |
| 2019-05-14 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2019-05-08 | 재확인 | Barrington Research | Outperform |
| 2018-08-09 | 재확인 | Barrington Research | Outperform |
| 2018-02-07 | 재확인 | Barrington Research | Outperform |
| 2018-01-02 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2017-11-08 | 재확인 | Barrington Research | Outperform |
| 2017-08-08 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2017-07-13 | 업그레이드 | JMP Securities | Mkt Perform → Mkt Outperform |
| 2017-02-07 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2016-11-08 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2016-11-07 | 재확인 | The Benchmark Company | Hold |
| 2016-09-20 | 다운그레이드 | CJS Securities | Market Outperform → Market Perform |
| 2016-08-15 | 다운그레이드 | Sidoti | Buy → Neutral |
| 2016-08-02 | 재확인 | Jefferies | Buy |
| 2016-08-02 | 재확인 | The Benchmark Company | Hold |
모두보기
Haemonetics Corp 주식(HAE)의 최신 뉴스
Haemonetics (HAE) Receives Updated Neutral Rating with Raised Pr - GuruFocus
Haemonetics price target raised to $74 from $62 at JPMorgan - TipRanks
Is it Apt to Retain Haemonetics Stock in Your Portfolio Now? - Yahoo Finance
Why Haemonetics (HAE) Stock Is Down Today - Finviz
Haemonetics (HAE) Downgraded to Neutral by Citigroup, Raises Pri - GuruFocus
Citigroup Downgrades Haemonetics to Neutral From Buy, Adjusts PT to $88 From $77 - marketscreener.com
Haemonetics downgraded to Neutral from Buy at Citi - TipRanks
BofA Securities Maintains Haemonetics(HAE.US) With Hold Rating, Raises Target Price to $90 - 富途牛牛
Haemonetics price target raised to $90 from $75 at BofA - TipRanks
Marshall Wace LLP Lowers Holdings in Haemonetics Corporation $HAE - MarketBeat
Norges Bank Makes New $36.82 Million Investment in Haemonetics Corporation $HAE - MarketBeat
Haemonetics (HAE): Reassessing Valuation After a 55% Three-Month Share Price Surge - simplywall.st
Haemonetics (NYSE:HAE) Reaches New 52-Week HighHere's Why - MarketBeat
Haemonetics Corporation $HAE Shares Acquired by Walleye Capital LLC - MarketBeat
XTX Topco Ltd Sells 24,831 Shares of Haemonetics Corporation $HAE - MarketBeat
Should You Be Adding Haemonetics (NYSE:HAE) To Your Watchlist Today? - Yahoo Finance
Capital Fund Management S.A. Makes New $995,000 Investment in Haemonetics Corporation $HAE - MarketBeat
Haemonetics Corporation (NYSE:HAE) Enhances Medical Innovation - Kalkine Media
Wall Street Zen Upgrades Haemonetics (NYSE:HAE) to "Buy" - MarketBeat
Haemonetics Corporation (NYSE:HAE) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Haemonetics stock hits 52-week high at $85.07 By Investing.com - Investing.com Canada
Haemonetics leverages insights from MassWomen conference - Traders Union
QSV Equity Investors LLC Makes New Investment in Haemonetics Corporation $HAE - MarketBeat
Can Haemonetics Corporation (HAZ) stock sustain free cash flowWeekly Profit Report & Long-Term Capital Growth Ideas - Newser
Will Haemonetics Corporation (HAZ) stock extend growth storyWeekly Trade Report & Technical Confirmation Trade Alerts - Newser
Will Haemonetics Corporation (HAZ) stock issue positive guidanceInsider Selling & Real-Time Stock Movement Alerts - Newser
Haemonetics Corporation (HAE) Stock Forecasts - Yahoo Finance
3-in-1 TAVR guidewire linked to faster procedures, less radiation - Cardiovascular Business
Fisher Asset Management LLC Cuts Position in Haemonetics Corporation $HAE - MarketBeat
Why Haemonetics Corporation stock could outperform next year2025 Market Outlook & High Conviction Buy Zone Alerts - Newser
Blood Bank Information Systems Market Projections 2025-2032: - openPR.com
Top 2 Health Care Stocks You May Want To Dump This Month - Sahm
Haemonetics Corporation $HAE Stock Position Increased by River Road Asset Management LLC - MarketBeat
TradeLink Capital LLC Acquires 5,128 Shares of Haemonetics Corporation $HAE - MarketBeat
Haemonetics Corporation $HAE Shares Sold by Schroder Investment Management Group - MarketBeat
Rhumbline Advisers Purchases 5,284 Shares of Haemonetics Corporation $HAE - MarketBeat
How Haemonetics Corporation stock benefits from digital adoptionEarnings Recap Report & Daily Oversold Stock Bounce Ideas - Newser
Can Haemonetics Corporation (HAZ) stock test all time highs2025 Valuation Update & Long-Term Growth Stock Strategies - Newser
Will Haemonetics Corporation stock recover faster than peersStock Surge & Scalable Portfolio Growth Ideas - Newser
Why retail traders accumulate Haemonetics Corporation stockQuarterly Earnings Summary & Verified Swing Trading Watchlist - Newser
Boston Partners Buys 11,738 Shares of Haemonetics Corporation $HAE - MarketBeat
Q1 EPS Estimates for Haemonetics Boosted by Zacks Research - MarketBeat
Is There Opportunity in Haemonetics After Shares Surge 57% on Expansion News? - simplywall.st
Q3 EPS Estimates for Haemonetics Decreased by Zacks Research - MarketBeat
Haemonetics Reaches Analyst Target Price - Nasdaq
Haemonetics Corporation $HAE Stock Position Raised by Geode Capital Management LLC - MarketBeat
BTIG Research Reiterates "Buy" Rating for Haemonetics (NYSE:HAE) - MarketBeat
Teleflex, Solventum, Haemonetics, Centene, and Molina Healthcare Shares Skyrocket, What You Need To Know - Barchart.com
Haemonetics stock holds Buy rating at BTIG on plasma segment strength - Investing.com
HAE: BTIG Reiterates Buy Rating with $88 Price Target | HAE Stoc - GuruFocus
How currency fluctuations impact Haemonetics Corporation stockEarnings Risk Report & Daily Oversold Stock Bounce Ideas - newser.com
Haemonetics Corp (HAE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.52%
0.28%
자본화:
|
볼륨(24시간):